verified that FGL2 might promote glioma growth in murine models by inhibiting the infiltration of immunosuppressive cells in the tumor microenvironment and that neutralization of FGL2 protein using anti-FGL2 antibody prolonged the survival time of mic (30). The gene discussed is FGL2; the disease is central nervous system cancer.